AMT-130 has been granted the FDA’s Regenerative Medicine Advance Therapy (RMAT) designation and Breakthrough Therapy designation, the first therapy for Huntington’s disease to receive an RMAT ...

Government agencies are continuously targeted by advanced persistent threats (APTs) from nation-state adversaries, requiring ...

Identities are today’s top attack vector. Here's how to build a layered security approach that reduces privilege risk across ...

The ambitious railway project that seeks to connect Panama with Paso Canoas, on the southern border with Costa Rica, is ...

Learn how to play Marvel Rivals like a pro with Esports Insider – master characters, game modes, and winning strategies in ...

Connecting to the Northwell VPN is usually the first step for most remote work. Think of it like building a private, secure ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, ...

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, has reported its ...

Universities must be able to operate independently, free from imposed political, ideological, or commercial influence. Institutional autonomy is not a privilege, but a necessary condition for ...

AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...

Itepekimab is a fully human monoclonal antibody that binds to and inhibits interleukin-33 (IL33), an initiator and amplifier of broad inflammation in COPD. IL33 is thought to be involved in different ...